MIWatch - Search Results

April 27, 2010

News: Seroquel settlement at $520 million

Admitting no wrong doing, AstraZeneca is expected to settle charges about off-label marketing Seroquel, according to a report in the New York Times. The British pharmaceutical still faces 25,000 law suits. . .
Full Story | Topics: legal, pharmaceutical, Seroquel | Comments (0)

March 18, 2010

News: Jury favors AstraZeneca in Seroquel trial
A jury decided AstraZeneca provided adequate warnings about side effects of Seroquel causing diabetes. The month-long trial in New Jersey has been carefully watched by 26,000 people with similar claims. The 7-1 ruling left unanswered whether the drug used to treat schizophrenia and bipolar disorder contributed to the onset of diabetes. . .
Full Story | Topics: ethics, legal, pharmaceutical, Seroquel | Comments (0)

March 2, 2010

News: Trial over Seroquel side effects continues

Seroquel watchers have been reporting on the New Jersey trial of AstraZeneca, alleged to have had prior knowledge of side effects of Seroquel causing excessive weight gain leading to diabetes, and heart disease. Internet coverage includes. . .
Full Story | Topics: legal, medication, pharmaceutical, Seroquel | Comments (1)

February 22, 2010

Consider This: A trial, and an ad, featuring Seroquel
. . .evidence vs. spin
Full Story | Topics: anxiety disorders, bipolar disorder, legal, medication, pharmaceutical, psychiatry, schizophrenia, Seroquel | Comments (0)

January 20, 2010

News: FDA cautions Zyprexa for teens

Metabolic side effects will become standard black box warnings for adolescents taking olanzapine (Zyprexa) as a result of an FDA ruling. The new guidelines. . .
Full Story | Topics: adolescents, FDA, medication, Seroquel, Zyprexa | Comments (1)

February 27, 2009

News: Seroquel trial
Allegations that AstraZeneca failed to warn patients that its drug Seroquel contributed to weight gain and diabetes came to light yesterday when documents were opened as part of a lawsuit over the billion dollar anti-psychotic drug. Instructions to divert direct questions about side effects advised the sales force to "neutralize" concerns about this despite knowing it's own doctor pointed to "reasonable evidence" about impaired glucose regulation." Court documents also reveal off-label use, and the vetting of negative trials. The case...
Full Story | Topics: chronic illness, drug trials, legal, pharmaceutical, Seroquel | Comments (3)

Connect with MIWatch

Subscribe via Email

Browse by Topic

addiction (46)
ADHD (19)
adolescents (34)
advance directives (6)
advocacy (64)
alcohol (10)
anxiety disorders (28)
Australia (1)
Berwick (1)
bipolar disorder (43)
Borderline Personality Disorder (1)
BP oil spill (1)
budget impacts (16)
California (1)
children (106)
chronic illness (28)
civil commitment (7)
CMS (1)
colleges (29)
community programs (49)
Complex PTSD (2)
conflicts-of-interest (4)
Congress (114)
consumers (23)
courts (27)
depression (131)
diagnosis (32)
disability rights (4)
disaster (12)
diversion programs (21)
drug companies (3)
drug trials (13)
drug use (23)
DSM-V (15)
eating disorders (4)
economy (5)
education (16)
elderly (32)
emergency (2)
emergency room (11)
Esmin Green (1)
ethics (9)
exercise (1)
family (33)
family caregiving (2)
FDA (31)
Florida (1)
FMAP (1)
genetics (17)
ghost writing (1)
health reform (19)
homeless (14)
hospitals (79)
housing (18)
human rights (25)
insurance (127)
insurannce (1)
investigation (20)
jails (11)
Kendras Law (4)
Kendras Law (1)
legal (68)
marijuana (11)
Medicaid (52)
Medicare (32)
medication (107)
mental health (33)
mental illness (10)
military (78)
NAMI (5)
Nemeroff (1)
New Mexico (1)
NIMH (1)
nursing homes (1)
obituary (3)
OCD (4)
panic disorder (5)
parity (47)
patient rights (9)
peer services (1)
personal narrative (1)
personality disorder (1)
pharmaceutical (83)
police (11)
policy (60)
politics (133)
poll (1)
poverty (1)
press (11)
prevention (9)
prisons (32)
Psychiatric Solutions (1)
psychiatry (30)
psychosis (15)
PTSD (86)
race (21)
recovery (71)
reform (60)
research (128)
Risperdal (1)
scandal (8)
schizophrenia (97)
schools (19)
Seroquel (6)
services (14)
states (23)
stigma (56)
students (33)
substance use (2)
suicide (75)
testimony (8)
Texas (1)
therapies (46)
trauma (2)
traumatic brain injury (1)
treatment programs (42)
Veterans Affairs (53)
violence (15)
women (11)
workplace (11)
Zyprexa (23)

MIWatch Archives